YDESW supply chain intelligence for YD Bio Ltd: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
YD Bio Ltd (YDESW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BNR | Burning Rock Biotech Limited | 72% | Reciprocal relationship from BNR graph: Reciprocal relationship from YDESW graph: ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s to… |
| BNR | Burning Rock Biotech Limited | 72% | ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Novartis, contributed approximately 54.7% of … |
| CAPR | Capricor Therapeutics, Inc. | 72% | Reciprocal relationship from CAPR graph: Reciprocal relationship from YDESW graph: ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s t… |
| CAPR | Capricor Therapeutics, Inc. | 72% | ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Novartis, contributed approximately 54.7% of … |
| EXAS | Exact Sciences Corp | 72% | Reciprocal relationship from EXAS graph: Reciprocal relationship from YDESW graph: ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s t… |
| EXAS | Exact Sciences Corp | 72% | ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Novartis, contributed approximately 54.7% of … |
| GH | Guardant Health, Inc. | 72% | Reciprocal relationship from GH graph: Reciprocal relationship from YDESW graph: Reciprocal relationship from GH graph: Reciprocal relationship from YDESW graph: Reciprocal relationship from GH graph… |
| GH | Guardant Health, Inc. | 72% | ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Novartis, contributed approximately 54.7% of … |
| JNJ | Johnson & Johnson | 72% | Reciprocal relationship from JNJ graph: Reciprocal relationship from YDESW graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from YDESW graph: Reciprocal relationship from JNJ gr… |
| JNJ | Johnson & Johnson | 72% | ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Novartis, contributed approximately 54.7% of … |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BNR | Burning Rock Biotech Limited | 72% | Reciprocal relationship from BNR graph: Reciprocal relationship from YDESW graph: Reciprocal relationship from BNR graph: Reciprocal relationship from YDESW graph: ontributed approximately 53.7% of t… |
| BNR | Burning Rock Biotech Limited | 72% | ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Novartis, contributed approximately 54.7% of … |
| CAPR | Capricor Therapeutics, Inc. | 72% | Reciprocal relationship from CAPR graph: Reciprocal relationship from YDESW graph: Reciprocal relationship from CAPR graph: Reciprocal relationship from YDESW graph: Reciprocal relationship from CAPR… |
| CAPR | Capricor Therapeutics, Inc. | 72% | ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Novartis, contributed approximately 54.7% of … |
| EXAS | Exact Sciences Corp | 72% | ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Novartis, contributed approximately 54.7% of … |
| EXAS | Exact Sciences Corp | 72% | Reciprocal relationship from EXAS graph: Reciprocal relationship from YDESW graph: Reciprocal relationship from EXAS graph: Reciprocal relationship from YDESW graph: Reciprocal relationship from EXAS… |
| GH | Guardant Health, Inc. | 72% | Reciprocal relationship from GH graph: Reciprocal relationship from YDESW graph: ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top… |
| GH | Guardant Health, Inc. | 72% | ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Novartis, contributed approximately 54.7% of … |
| JNJ | Johnson & Johnson | 72% | ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Novartis, contributed approximately 54.7% of … |
| JNJ | Johnson & Johnson | 72% | Reciprocal relationship from JNJ graph: Reciprocal relationship from YDESW graph: ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s to… |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| EXAS | Exact Sciences Corp | 100.00 | 1 | ['customer', 'supplier'] |
| GH | Guardant Health, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| CAPR | Capricor Therapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| BNR | Burning Rock Biotech Limited | 100.00 | 1 | ['customer', 'supplier'] |
| JNJ | Johnson & Johnson | 100.00 | 1 | ['customer', 'supplier'] |
| AVBP | ArriVent BioPharma, Inc. | 50.00 | 2 | |
| AORT | Artivion, Inc. | 50.00 | 2 | |
| CVRX | CVRx, Inc. | 50.00 | 2 | |
| CBIH | Cannabis Bioscience International Holdings, Inc. | 50.00 | 2 | |
| CYCN | Cyclerion Therapeutics, Inc. | 50.00 | 2 | |
| BNRG | Brenmiller Energy Ltd | 50.00 | 2 | |
| AVTX | Avalo Therapeutics, Inc. | 50.00 | 2 | |
| CSTE | Caesarstone Ltd. | 50.00 | 2 | |
| DYAI | Dyadic International, Inc. | 50.00 | 2 | |
| SNNUF | Smith & Nephew plc | 50.00 | 2 | |
| GRAL | GRAIL, Inc. | 50.00 | 2 | |
| PSNL | Personalis, Inc. | 50.00 | 2 | |
| ALC | Alcon Inc. | 50.00 | 2 | |
| ATRA | Atara Biotherapeutics, Inc. | 50.00 | 2 | |
| CYTOF | Altamira Therapeutics Ltd. | 50.00 | 2 |